Cross-atlantic modification and validation of the a tool to assess quality of life in idiopathic pulmonary fibrosis (ATAQ-IPF-cA)

BMJ Open Respiratory Research

Volumn 1, Issue 1, 2016, Pages

  Yorke, Janelle ^a,b   Spencer, Lisa G ^c   Duck, Annette ^b   Ratcliffe, Sarah ^d   Kwong, G Ngman ^e   Longshaw, Mark S ^f   Belkin, Amanda ^g   Swigris, Jeffrey J ^g  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF SALFORD   (United Kingdom)

^e FAIRFIELD GENERAL HOSPITAL   (United Kingdom)

^f NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^g DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

A TOOL TO ASSESS QUALITY OF LIFE IN IDIOPATHIC PULMONARY FIBROSIS; AGED; ARTICLE; ASSESSMENT OF HUMANS; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUGHING; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSPNEA; ENERGY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; INDEPENDENCE; INFORMATION PROCESSING; INTERNAL CONSISTENCY; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL DYSPNOEA SCALE; MENTAL HEALTH; OUTCOME ASSESSMENT; OXYGEN SUPPLY; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RASCH ANALYSIS; RELIGION; SEXUALITY; SLEEP; SOCIAL BEHAVIOR; VALIDATION PROCESS;

EID: 85006685003     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2014-000024     Document Type: Article

References (19)

1. Raghu G, Collard H, Egan J, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.
2. Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980–5.
3. Schoenheit G, Becattelli I, Cohen AH. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis 2011;8:225–31.
4. Swigris JJ, Stewart AL, Gould MK, et al. Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005;3:61.
5. Ware J Jr, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
6. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25–31; discussion 33–27.
7. Swigris JJ, Wilson SR, Green KE, et al. Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes 2010;8:77.
8. Johnson T, Kulesa P, Llc I, et al. The relation between culture and response styles: evidence from 19 countries Timothy Johnson. J Cross Cult Psychol 2005;36:264–77.
9. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–36.
10. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319–38.
11. Crapo R, Morris A. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123:185–9.
12. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21–6.
13. Yorke J, Swigris J, Russell AM, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011;139:159–64.
14. Brodersen J, Meads D, Kreiner S, et al. Methodological aspects of differential item functioning in the Rasch model. J Medical Economics 2007;10:309–24.
15. Pallant JF, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007;46:1–18.
16. Swigris JJ, Yorke J, Sprunger DB, et al. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. Respir Med 2010;104:1350–5.
17. McInnes RA. Chronic illness and sexuality. Med J Aust 2003;179:263–6.
18. Belkin A, Albright K, Swigris J. A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Resp Res 2013;1:e000007.
19. Tennant A, Penta M, Tesio L, et al. Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Med Care 2004;42:I37–48.